AllianzGI Health Sciences Fund Class B (RBGHX)

31.49
Net Asset Value
+0.99%
1 Day
+13.60%
Year-to-Date
Overall Morningstar Rating
Health
Style or Category
No Load
Sales Expenses
2.21%
Expense Ratio
Average
Morningstar Risk Rating™
Investment Objective The investment seeks long-term capital appreciation. The fund seeks to achieve its objective by normally investing at least 80% of its net assets (plus borrowings made for investment purposes) in health sciences-related companies. The portfolio managers consider health sciences-related companies to include companies that design, manufacture or sell products or services used for or in connection with healthcare, medicine or life sciences or that otherwise promote healthy living. The fund will invest primarily in common stocks and other equity securities. It is non-diversified.

Performance

1 month+4.06% 3 years+24.70%
3 months+13.11% 5 years+18.72%
1 year+34.14% Since inception+8.27%
Data through --

Peer Comparisonvs. Health

 RBGHXCategory
Performance 5-yr return+18.72%+21.57%
Expense ratio2.21%1.45%
Risk 5 year sharpe ratio1.401.52
Net assets$199.4M$3.7B
Average market cap$30.1B$32.9B
Average P/E29.326.3
Portfolio turnover119%119%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyAllianz Funds
Fund manager & tenureMichael Dauchot / 10 Years
Minimal initial investment$1,000.00
Minimum IRA investment$1,000.00

Holdings

U.S. stock76.60%
International stock18.51%
Cash3.77%
Fixed income1.12%
Other0.00%
Top 5 Sectors
Portfolio weighting
Healthcare 81.95%
Consumer goods 9.88%
Consumer service 4.31%
Hardware 2.62%
Business service 0.00%
Top 10 Holdings
Portfolio weighting
ACT Actavis4.62%
MNK Mallinckrodt Plc4.35%
CELG Celgene3.64%
JNJ Johnson & Johnson3.45%
MRK Merck3.28%
VRTX Vertex Pharmaceuticals Inc3.19%
-- 3.12%
BSX Boston Scientific Corp3.04%
BIIB Biogen2.88%
SNY Sanofi2.87%

To view my watchlist

Not a member yet?

Sign up now for a free account